glp-1 shortage over FDA says that the is GLP-1s Going Direct, How Novo

They also recommend them as a possible initial treatment in those with diabetes and certain comorbidities such as obesity, chronic kidney disease and prior significant cardiovascular events

Healey pointed to anticipated federal Medicaid cuts as an additional budget challenge

Even side effects are rare, temporary, and mild

Elsevier, Woodhead Publishing, pp 187210

The weight reduction observed with GLP-1 therapy is not merely a side effect but represents a therapeutic benefit for many patients with type 2 diabetes, who often struggle with overweight or obesity

A tear may produce pain, swelling, stiffness, limited range of motion, and mechanical symptoms such as catching or locking